FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Commerce Committee Probes FDA Internal Disputes

[ Price : $8.95]

The U.S. House Energy and Commerce Committees Republican leadership opens an investigation into FDAs handling of internal scientif...

Laurus Synthesis FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 issued to Indias Laurus Synthesis with five inspection observations.

Torrent Pharmaceuticals FDA-483

[ Price : $8.95]

FDA releases the form FDA-483 issued following an inspection at Indias Torrent Pharmaceuticals drug manufacturing facility.

No FDA Funding for RADAR: Public Citizen

[ Price : $8.95]

Public Citizen asks FDA to revise its planned research on the misuse of drugs and other substances to ensure that no funding goes ...

FDA Alert on Synovo Hip Implants

[ Price : $8.95]

FDA alerts healthcare providers to not purchase or implant Synovos Total Hip System because modifications to the original device d...

EUA Filed for Covid Prevention in Immunocompromised

[ Price : $8.95]

Invivyd seeks FDA emergency use authorization for VYD222, which is described as a broadly neutralizing, half-life extended monoclo...

FDA OKs Arcutis Zoryve Topical Foam for Dermatitis

[ Price : $8.95]

FDA approves Arcutis Biotherapeutics Zoryve topical foam to treat seborrheic dermatitis in individuals aged nine and older.

Complete Response Letter for Zealand Infant Drug

[ Price : $8.95]

FDA issues a complete response letter for Zealand Pharmas dasiglucagon based on deficiencies at a third-party manufacturing facili...

FDA Updates Kite Yescarta Label

[ Price : $8.95]

FDA approves a label update for Kites Yescarta to include the overall survival primary analysis from the landmark Phase 3 Zuma-7 s...

No Info from Singapore Drug Company

[ Price : $8.95]

FDA warns Singapores Wipro Unza Singapore Private, Limited, about refusing to respond to two agency records requests for informati...